| Literature DB >> 31940681 |
Seung Hyun Back1, Hong Sik Eom1, Haeng Ho Lee1, Gi Yong Lee1, Kun Taek Park2, Soo Jin Yang3.
Abstract
The emergence of livestock-associated (LA)-<span class="Chemical">methicillin-resistant <span class="Species">Staphylococcus aureus (MRSA) in livestock animal has become a significant zoonotic concern. In the present study, we investigated nationwide prevalence of LA-MRSA across pork production chain including pig farms, slaughterhouses, and retail markets. A total of 40 MRSA strains were isolated during the investigation and the overall prevalence of MRSA was 3.4% (n = 37), 0.6% (n = 2), and 0.4% (n = 1) in pig farms, slaughterhouses, and retail markets, respectively. Multilocus sequence typing analyses revealed that the 2 most significant clonal lineages in pork production chain in Korea were ST398 (n = 25) and ST541 (n = 6). All of the 40 MRSA isolates were further characterized to investigate key genotypic and phenotypic correlates associated with the emergence and spread of clonal complex 398 (CC398; ST398, and ST541) LA-MRSA. Although the prevalence of swine-associated MRSA was still relatively low and mostly restricted to pig farms, multidrug-resistant CC398 LA-MRSA isolates with new spa types (t18102 and t18103) were identified as a major clonal lineage. The CC398 LA-MRSA strains tended to exhibit increased levels of multiple drug resistance (MDR) phenotype compared with non-CC398 MRSA strains. Of note, in comparison with non-CC398 MRSA isolates, CC398 LA-MRSA isolates exhibited significantly enhanced tetracycline (TET) and zinc resistance. These findings suggested that co-selection pressure associated with MDR phenotype, especially TET resistance, and zinc resistance may have played a significant role in the emergence and persistence of CC398 LA-MRSA in pig farms in Korea.Entities:
Keywords: CC398; MRSA; antimicrobial resistance; swine; zinc resistance
Year: 2020 PMID: 31940681 PMCID: PMC7000904 DOI: 10.4142/jvs.2020.21.e2
Source DB: PubMed Journal: J Vet Sci ISSN: 1229-845X Impact factor: 1.672
Prevalence of MRSA isolates in pig farms, slaughterhouses, and retail markets in Korea
| Sample origin | Provinces | Total | |||||
|---|---|---|---|---|---|---|---|
| Gyeonggi | Gangwon | Chungcheong | Jeolla | Gyeongsang | |||
| Farms | 0/178 | 0/160 | 11/228 (4.8) | 17/259 (6.6) | 9/254 (3.5) | 37/1,079 (3.4) | |
| Pigs | 0/120 | 0/120 | 7/160 (4.3) | 13/200 (6.5) | 8/200 (4.0) | 28/800 (3.5) | |
| Workers | 0/40 | 0/32 | 4/44 (9.0) | 1/29 (3.4) | 0/24 | 5/169 (3.0) | |
| Environment | 0/18 | 0/18 | 0/24 | 3/30 (10.0) | 1/30 (3.3) | 4/120 (3.3) | |
| Slaughterhouses | 0/40 | 0/43 | 0/43 | 2/142 (1.4) | 0/43 | 2/311 (0.6) | |
| Carcass | 0/40 | 0/40 | 0/40 | 1/120 (0.8) | 0/40 | 1/280 (0.4) | |
| Workers | - | - | - | 1/13 (7.6) | - | 1/13 (7.6) | |
| Environment | - | 0/3 | 0/3 | 0/9 | 0/3 | 0/21 | |
| Retail markets | 0/65 | 1/42 (2.4) | 0/55 | 0/54 | 0/51 | 1/267 (0.4) | |
| Pork meats | 0/58 | 1/42 (2.4) | 0/55 | 0/54 | 0/51 | 1/260 (3.8) | |
| Workers | 0/4 | - | - | - | - | 0/4 | |
| Environment | 0/3 | - | - | - | - | 0/3 | |
| Total | 0/283 | 1/245 (0.4) | 11/326 (3.4) | 19/455 (4.2) | 9/348 (2.6) | 40/1,657 (2.4) | |
Data are shown as number of MRSA/total number of samples (% of MRSA isolation).
MRSA, methicillin-resistant Staphylococcus aureus.
Fig. 1Prevalence and genetic profiles of MRSA isolates recovered from pig farms, slaughterhouses, and retail markets. Each square represents individual MRSA isolate and staphylococcal cassette chromosome mec type II, IV, V, or N is shown in the square.
MRSA, methicillin-resistant Staphylococcus aureus; NT, non-typeable for multilocus sequence typing; ST, sequence type; N, non-typeable.
Genotypes, antimicrobial resistance profiles, virulence factors, and zinc chloride susceptibility of methicillin-resistant Staphylococcus aureus strains
| Isolates | MLST | Origin | SCC | Places | Resistance phenotype | TET MICs (µg/mL) | Zinc MICs (µg/mL) | ETs TSST PVL | SEs | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PKFA-1101 | ST398 | Pig | t18102 | V | I | F-1 | AMP, CHL, CEF, TET, CIP | 64 | + | 10 | |||
| PKFA-181 | Pig | t18102 | V | I | F-1 | AMP, CHL, CEF, TET, CIP | 64 | + | 10 | ||||
| PKFA-191 | Pig | t18102 | V | I | F-1 | AMP, CHL, CEF, TET, CIP | 64 | + | 10 | ||||
| PKFA-111 | Pig | t18102 | V | I | F-1 | AMP, CHL, CEF, TET, CIP | 64 | + | 10 | ||||
| PKFA-171 | Pig | t18102 | V | I | F-1 | AMP, CHL, CEF, TET, CIP | 32 | + | 10 | ||||
| PKFA-151 | Pig | t571 | V | I | F-1 | AMP, CHL, CEF, TET, CIP | 64 | + | 10 | ||||
| PJFA-3101 | Pig | t571 | NT | I | F-2 | AMP, CHL, CLI, ERY, CEF, GEN, SYN, TET, CIP | 32 | + | 10 | ||||
| PJFA-561 | Pig | t18103 | V | I | F-3 | AMP, CHL, CLI, ERY, CEF, GEN, SYN, TET, CIP | 64 | + | 4 | ||||
| PJFA-511 | Pig | t18103 | V | I | F-3 | AMP, CHL, CLI, ERY, CEF, GEN, SYN, TET, CIP | 64 | + | 4 | ||||
| PJFA-521M | Pig | t18103 | V | I | F-3 | AMP, CHL, CLI, ERY, CEF, GEN, SYN, TET, CIP | 64 | + | 4 | ||||
| PJFA-531M | Pig | t18103 | V | I | F-3 | AMP, CHL, CLI, ERY, CEF, GEN, SYN, TET, CIP | 64 | − | 4 | ||||
| PJFA-541M | Pig | t18103 | V | I | F-3 | AMP, CHL, CLI, ERY, CEF, GEN, SYN, TET, CIP | 128 | + | 4 | ||||
| PJFA-551M | Pig | t18103 | V | I | F-3 | AMP, CHL, CLI, ERY, CEF, GEN, SYN, TET, CIP | 64 | + | 4 | ||||
| PJFA-581M | Pig | t18103 | V | I | F-3 | AMP, CHL, CLI, ERY, CEF, GEN, SYN, TET, CIP | 64 | + | 4 | ||||
| PJFA-591M | Pig | t18103 | V | I | F-3 | AMP, CHL, CLI, ERY, CEF, GEN, SYN, TET, CIP | 128 | − | 4 | ||||
| PJFA-5101M | Pig | t18103 | V | I | F-3 | AMP, CHL, CLI, ERY, CEF, GEN, SYN, TET, CIP | 64 | + | 4 | ||||
| PKFA-163 | Pig | t571 | NT | I | F-1 | AMP, CHL, CLI, ERY, CEF, GEN, TET, CIP | 32 | + | 12 | ||||
| PJFA-573 | Pig | t18103 | V | I | F-3 | AMP, CHL, CLI, ERY, CEF, GEN, SYN, TET, CIP | 64 | + | 6 | ||||
| PKFA-124 | Pig | t18102 | V | I | F-1 | AMP, CHL, CEF, TET, CIP | 64 | + | 10 | ||||
| PJFH-522M | Worker | t18103 | V | I | F-3 | AMP, CHL, CLI, ERY, CEF, GEN, TET, CIP | 64 | − | 4 | ||||
| PKFE-102-1 | Environ. | t18102 | V | I | F-1 | AMP, CHL, CEF, TET, CIP | 64 | + | 10 | ||||
| PJFE-502 | Environ. | t18103 | V | I | F-3 | AMP, CHL, CLI, ERY, CEF, GEN, SYN, TET, CIP | 64 | − | 4 | ||||
| PJFE-503 | Environ. | t18103 | V | I | F-3 | AMP, CHL, CLI, ERY, CEF, GEN, SYN, TET, CIP | 128 | + | 4 | ||||
| PJFE-504 | Environ. | t18103 | V | I | F-3 | AMP, CHL, CLI, ERY, CEF, GEN, SYN, TET, CIP | 128 | + | 4 | ||||
| PJSM-251E | Carcass | t571 | V | I | S-1 | AMP, CHL, CEF, TET, CIP | 64 | + | 10 | ||||
| PCFA-221 | ST541 | Pig | t034 | V | I | F-4 | AMP, CLI, ERY, CEF, TET | 64 | + | 6 | |||
| PCFA-231 | Pig | t034 | V | I | F-4 | AMP, CLI, ERY, CEF, TET | 16 | − | 4 | ||||
| PCFA-263 | Pig | t034 | V | I | F-4 | AMP, CLI, ERY, CEF, TET | 64 | + | 6 | ||||
| PCFA-254 | Pig | t034 | V | I | F-4 | AMP, CLI, ERY, CEF, TET | 16 | + | 6 | ||||
| PCFA-244 | Pig | t034 | V | I | F-4 | AMP, CLI, ERY, CEF, TET | 16 | + | 6 | ||||
| PCFH-226 | Worker | t034 | V | I | F-4 | AMP, CLI, ERY, CEF, TET | 64 | + | 6 | ||||
| PCFH-321 | ST2084 | Worker | t664 | IV | I | F-5 | AMP, ERY, CEF | < 0.25 | − | 4 | |||
| PCFH-322 | Worker | t5440 | IV | I | F-5 | AMP, ERY, CEF | < 0.25 | − | 4 | ||||
| PCFH-326 | Worker | t664 | IV | I | F-5 | AMP, ERY, CEF, STX | < 0.25 | − | 4 | ||||
| PJSH-331E | Worker | t5440 | IV | I | S-2 | AMP, CEF | 0.5 | − | 4 | ||||
| PCFA-3102 | ST5 | Pig | t9353 | IV | I | F-5 | AMP, CLI, ERY, CEF, TET, CIP, MUP | 16 | − | 4 | |||
| PGMM-711 | Pork | t2460 | II | II | R-1 | AMP, CLI, ERY, CEF, GEN, TET, CIP | 16 | − | 4 | ||||
| PCFA-442 | ST1 | Pig | t128 | IV | III | F-12 | AMP, CEF | < 0.25 | + | 4 | |||
| PJFA-423 | Pig | t128 | IV | III | F-6 | AMP, CEF, GEN, STX, SYN, CIP | < 0.25 | + | 4 | ||||
| PJFA-393 | NT | Pig | t901 | IV | I | F-2 | AMP, ERY, CEF | < 0.25 | + | 6 |
MLST, multilocus sequence typing; ST, sequence type; SCCmec, staphylococcal cassette chromosome mec; MIC, minimum inhibitory concentrations; ET, exfoliative toxin; TSST, toxic shock syndrome toxin; PVL, Panton-Valentine leukocidin; SE, staphylococcal enterotoxin; NT, non-typeable; F, farms; S, slaughterhouses; R, retail markets; AMP, ampicillin; CHL, chloramphenicol; CLI, clindamycin; ERY, erythromycin; CEF, cefoxitin; GEN, gentamicin; RIF, rifampicin; SXT, sulfamethoxazole-trimethoprim; SYN, quinupristin-dalfopristin; MUP, mupirocin; TET, tetracycline; CIP, ciprofloxacin.
Fig. 2Antimicrobial susceptibility and frequency of MDR phenotype. Antimicrobial susceptibility of (A) CC398 and (B) non-CC398 MRSA isolates and frequency of a MDR phenotype among (C) CC398 and (D) non-CC398 MRSA isolates. Susceptibility assays were performed using the disc diffusion methods according to the 2017 Clinical and Laboratory Standards Institute guidelines [17].
MDR, multidrug resistance; MRSA, methicillin-resistant Staphylococcus aureus; AMP, ampicillin; CHL, chloramphenicol; CLI, clindamycin; ERY, erythromycin; CEF, cefoxitin; GEN, gentamicin; RIF, rifampicin; SXT, trimethoprim-sulfamethoxazole; SYN, quinupristin-dalfopristin; TET, tetracycline; CIP, ciprofloxacin; MUP, mupirocin.
Fig. 3Box and Whisker plots of TET MICs (A) and MBCs (B) for CC398 and non-CC398 MRSA isolates. The median TET MICs for CC398 and non-CC398 MRSA isolates were 64.59 µg/mL and 3.778 µg/mL, respectively (p = 0.0001). The median TET MBCs for CC398 and non-CC398 MRSA isolates were 192.5 µg/mL and 7.667 µg/mL, respectively (p = 0.0004).
MIC, minimum inhibitory concentration; MBC, minimum bactericidal concentration; MRSA, methicillin-resistant Staphylococcus aureus; TET, tetracycline.
Fig. 4Box and Whisker plots of zinc chloride MICs for CC398 and non-CC398 MRSA isolates. The median zinc chloride MICs for CC398 and nonCC398 MRSA isolates were 6.581 µg/mL and 4.222 µg/mL, respectively (p = 0.0027).
MIC, minimum inhibitory concentration; MRSA, methicillin-resistant Staphylococcus aureus.